P023: The clinical utility of plasma Lyso-Gb3 in the diagnosis of Fabry disease in infants and adults

P023: The clinical utility of plasma Lyso-Gb3 in the diagnosis of Fabry disease in infants and adults

Bibliographic Details
Main Authors:	Wenjiao Li, Brandon Stauffer, Hongjie Chen, Jing Xiao, Yu Leng Phua, Neal Cody, Lisa Edelmann, Ruth Kornreich, Robert Desnick, Chunli Yu
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Genetics in Medicine Open
Online Access:	http://www.sciencedirect.com/science/article/pii/S294977442300033X

Similar Items

P031: Fabry disease: Genotype/phenotype correlations for 17 novel GLA mutations by GLA activity and plasma Lyso-Gb3 levels
by: Neal Cody, et al.
Published: (2023-01-01)

Migalastat HCl reduces globotriaosylsphingosine (lyso-Gb3) in Fabry transgenic mice and in the plasma of Fabry patients.
by: Brandy Young-Gqamana, et al.
Published: (2013-01-01)

Lyso-Gb3 Increases αvβ3 Integrin Gene Expression in Cultured Human Podocytes in Fabry Nephropathy
by: Hernán Trimarchi, et al.
Published: (2020-11-01)

Nano-LC-MS/MS for Quantification of Lyso-Gb3 and Its Analogues Reveals a Useful Biomarker for Fabry Disease.
by: Hideaki Sueoka, et al.
Published: (2015-01-01)

Elevated LysoGb3 Concentration in the Neuronopathic Forms of Mucopolysaccharidoses
by: Galina Baydakova, et al.
Published: (2020-03-01)

Sex differences of urinary and kidney globotriaosylceramide and lyso-globotriaosylceramide in Fabry mice
by: Brandon Durant, et al.
Published: (2011-09-01)

RIPK3 Contributes to Lyso-Gb3-Induced Podocyte Death
by: So-Young Kim, et al.
Published: (2021-01-01)

Long-term effect of antibodies against infused alpha-galactosidase A in Fabry disease on plasma and urinary (lyso)Gb3 reduction and treatment outcome.
by: Saskia M Rombach, et al.
Published: (2012-01-01)

Contribution of Glucosylsphingosine (Lyso-Gb1) to Treatment Decisions in Patients with Gaucher Disease
by: Tama Dinur, et al.
Published: (2023-02-01)

Insights into the Value of Lyso-Gb1 as a Predictive Biomarker in Treatment-Naïve Patients with Gaucher Disease Type 1 in the LYSO-PROOF Study
by: Filipa Curado, et al.
Published: (2023-08-01)

Glucosylsphingosine (Lyso-Gb1) as a reliable biomarker in Gaucher disease: a narrative review
by: Gaetano Giuffrida, et al.
Published: (2023-02-01)

Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review
by: Shoshana Revel-Vilk, et al.
Published: (2020-09-01)

Glucosylsphingosine (Lyso-Gb<sub>1</sub>): An Informative Biomarker in the Clinical Monitoring of Patients with Gaucher Disease
by: Matthew M. Gayed, et al.
Published: (2022-11-01)

A Rapid and Simple UHPLC-MS/MS Method for Quantification of Plasma Globotriaosylsphingosine (lyso-Gb3)
by: Alessandro Perrone, et al.
Published: (2021-12-01)

Gaucher Disease Diagnosis Using Lyso-Gb1 on Dry Blood Spot Samples: Time to Change the Paradigm?
by: Tama Dinur, et al.
Published: (2022-01-01)

Treatment Efficiency in Gaucher Patients Can Reliably Be Monitored by Quantification of Lyso-Gb1 Concentrations in Dried Blood Spots
by: Claudia Cozma, et al.
Published: (2020-06-01)

Effect of Ambroxol chaperone therapy on Glucosylsphingosine (Lyso-Gb1) levels in two Canadian patients with type 3 Gaucher disease
by: Behshad Charkhand, et al.
Published: (2019-09-01)

An observational study to investigate the relationship between plasma glucosylsphingosine (lyso-Gb1) concentration and treatment outcomes of patients with Gaucher disease in Japan
by: Hiroyuki Ida, et al.
Published: (2022-11-01)

Plasma lyso-sphingomyelin levels are positively associated with clinical severity in acid sphingomyelinase deficiency
by: Margo Sheck Breilyn, et al.
Published: (2021-09-01)

Lyso-IP: Uncovering Pathogenic Mechanisms of Lysosomal Dysfunction
by: Chase Chen, et al.
Published: (2022-04-01)

Fabry cardiomyopathy: Gb3‐induced auto‐reactive panmyocarditis requiring heart transplantation
by: Andrea Frustaci, et al.
Published: (2020-06-01)

Using Liquid Chromatography-Tandem Mass Spectrometry in Detecting Plasma Lyso-GL3 Levels in Patients with Fabry Disease and the Association Analysis of Phenotype-Genotype of the Disease
by: OUYANG Yan, et al.
Published: (2024-01-01)

Parkinson's disease prevalence in Fabry disease: A survey study
by: Adina H. Wise, et al.
Published: (2018-03-01)

Predictions for Bottomonia Suppression in 5.023 TeV Pb-Pb Collisions
by: Brandon Krouppa, et al.
Published: (2016-08-01)

Recognition of lyso-phospholipids by human natural killer T lymphocytes.
by: Lisa M Fox, et al.
Published: (2009-10-01)

A Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometric Assay for the Quantification of Fabry Disease Biomarker Globotriaosylceramide (GB3) in Fabry Model Mouse
by: Seok-Ho Shin, et al.
Published: (2018-06-01)

Impact of Long-Term Enzyme Replacement Therapy on Glucosylsphingosine (Lyso-Gb1) Values in Patients with Type 1 Gaucher Disease: Statistical Models for Comparing Three Enzymatic Formulations
by: Tama Dinur, et al.
Published: (2021-07-01)

Circulating Anti-GB3 Antibody as a Biomarker of Myocardial Inflammation in Patients with Fabry Disease Cardiomyopathy
by: Andrea Frustaci, et al.
Published: (2023-06-01)

The genomic landscape of 2,023 colorectal cancers
by: Cornish, AJ, et al.
Published: (2024)

RGP023 - FIZIK UNTUK PBP - OKTOBER 1987.
by: PPPB, Pusat Pengajian Perumahan Dan Bangunan
Published: (1987)

Proteomic analysis unveils Gb3-independent alterations and mitochondrial dysfunction in a gla −/− zebrafish model of Fabry disease
by: Hassan Osman Alhassan Elsaid, et al.
Published: (2023-09-01)

A Brazilian Rare-Disease Center’s Experience with Glucosylsphingosine (lyso-Gb1) in Patients with Gaucher Disease: Exploring a Novel Correlation with IgG Levels in Plasma and a Biomarker Measurement in CSF
by: Matheus Vernet Machado Bressan Wilke, et al.
Published: (2024-03-01)

Ce:LYSO, from scintillator to solid-state lighting as a blue luminescent concentrator
by: Lisa Lopez, et al.
Published: (2023-05-01)

YWP 301/NKM 023 - Penulisan Berita November 1995
by: PPIK, Pusat Pengajian Ilmu Kemanusiaan
Published: (1995)

Derivation of human embryonic stem cell line Genea023
by: Biljana Dumevska, et al.
Published: (2016-03-01)

Investigation of Electron Capture in 176Lu with a LYSO crystal scintillator
by: Nozzoli Francesco, et al.
Published: (2023-01-01)

A Study of Multiple Scattering in BGO and LYSO Single Crystal Scintillators
by: Kittipong Seingsanoh, et al.
Published: (2016-08-01)

Coincidence energy spectra due to the intrinsic radioactivity of LYSO scintillation crystals
by: Francisco Eduardo Enríquez-Mier-y-Terán, et al.
Published: (2020-04-01)

Neutrosophic gb-closed Sets and Neutrosophic gb-Continuity
by: C.Maheswari, et al.
Published: (2019-11-01)

YMP 204-NKM 023 - KEWARTAWANAN I APRIL 1993.pdf
by: PPK, Pusat Pengajian Komunikasi
Published: (1993)